ARS Pharmaceuticals, Inc.
SPRYBiotechnology
$3.66+0.27%As of Oct 29vs prior close
- Market cap
- $364M
- P/E (TTM)
- –
- From 52W high
- −71.98%
- EPS (LTM)
- -$2.17
- Revenue (LTM)
- $116.9M
- Net margin
- -184.24%
- Dividend yield
- 0.00%
Nomior Score
21
Speculative ChargeBottom 8% of the scored universe
Growth71
Quality28
Value38
Momentum11
Resilience22
Growth
+97.80%revenue a year over 4 fiscal years
YE21 $5.5MLTM $116.9M
Connections
Revenue to profitQ2 YE26
The operating loss was 183% of revenue, narrower by 120 pts on a year.
Who owns it
2funds, 1 tracked portfolio